Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05902871 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population

Study acronym: Zhuiguangzhe
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date changed from estimate of Jul 2026 to Jul 2, 2026v5
  2. Trial status: Recruiting to Active, Not Recruitingv4 Show 4 more changesShow less
    • Enrollment target: estimated 45 to confirmed 40
    • Primary completion date: Oct 2026 to Jul 2026
    • Study completion date: Mar 2027 to Jan 2027
    • Site details revised at 2 of 2 sites
  3. Site details revised at 1 of 2 sitesv3
  4. Trial status: Not Yet Recruiting to Recruitingv2 Show 12 more changesShow less
    • Enrollment target: 65 to 45
    • Primary completion date: Jun 24, 2024 to Oct 2026
    • Start date changed from estimate of Jun 15, 2023 to Mar 11, 2024
    • Primary endpoint revised
    • Study completion date: Dec 24, 2024 to Mar 2027
    • Interventions: Eagle (Device) to Direct Selective Laser Trabeculoplasty (Procedure), External Automatic Glaucoma Laser (Device)
    • Eligibility criteria shortened, about 394 words
    • Secondary endpoints revised (3)
    • Study description shortened, about 572 words
    • Study arms: 1 to 2
    • Collaborators shortened, about 4 words
    • Study title shortened, about 1 word
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this study is to evaluate the safety and effectiveness of Direct Selective Laser Trabeculoplasty (DSLT) in ethnic Chinese participants with Primary Open Angle Glaucoma (POAG), Ocular Hypertension (OHT), or Normal Tension Glaucoma (NTG).
Trial Details
NCT Number NCT05902871
Lead Sponsor BelkinVision
Conditions
(from sponsor)		 Primary Open Angle Glaucoma, Ocular Hypertension, Normal Tension Glaucoma
Related terms Glaucoma, Glaucoma, Open-Angle, Low Tension Glaucoma, Ocular Hypertension
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov